Lucid Diagnostics Inc.

Healthcare · Medical Devices · United States

Last price 0.4323 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 82.55M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company’s flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in ...